The thrombomodulin-protein C system is essential for the maintenance of pregnancy

被引:209
作者
Isermann, B
Sood, R
Pawlinski, R
Zogg, M
Kalloway, S
Degen, JL
Mackman, N
Weiler, H
机构
[1] Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53233 USA
[2] Scripps Res Inst, Dept Immunol & Vasc Biol, La Jolla, CA USA
[3] Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA
[4] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA
关键词
D O I
10.1038/nm825
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Disruption of the mouse gene encoding the blood coagulation inhibitor thrombomodulin (Thbd) leads to embryonic lethality caused by an unknown defect in the placenta. We show that the abortion of thrombomodulin-deficient embryos is caused by tissue factor-initiated activation of the blood coagulation cascade at the feto-maternal interface. Activated coagulation factors induce cell death and growth inhibition of placental trophoblast cells by two distinct mechanisms. The death of giant trophoblast cells is caused by conversion of the thrombin substrate fibrinogen to fibrin and subsequent formation of fibrin degradation products. In contrast, the growth arrest of trophoblast cells is not mediated by fibrin, but is a likely result of engagement of protease-activated receptors (PAR)-2 and PAR-4 by coagulation factors. These findings show a new function for the thrombomodulin-protein C system in controlling the growth and survival of trophoblast cells in the placenta. This function is essential for the maintenance of pregnancy.
引用
收藏
页码:331 / 337
页数:7
相关论文
共 46 条
[41]   A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state [J].
Weiler-Guettler, H ;
Christie, PD ;
Beeler, DL ;
Healy, AM ;
Hancock, WW ;
Rayburn, H ;
Edelberg, JM ;
Rosenberg, RD .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (09) :1983-1991
[42]   Targeting of transgene expression to the vascular endothelium of mice by homologous recombination at the thrombomodulin locus [J].
WeilerGuettler, H ;
Aird, WC ;
Husain, M ;
Rayburn, H ;
Rosenberg, RD .
CIRCULATION RESEARCH, 1996, 78 (02) :180-187
[43]  
WeilerGuettler H, 1996, DEVELOPMENT, V122, P2271
[44]   CLOT-BOUND THROMBIN IS PROTECTED FROM INHIBITION BY HEPARIN-ANTITHROMBIN-III BUT IS SUSCEPTIBLE TO INACTIVATION BY ANTITHROMBIN-III-INDEPENDENT INHIBITORS [J].
WEITZ, JI ;
HUDOBA, M ;
MASSEL, D ;
MARAGANORE, J ;
HIRSH, J .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02) :385-391
[45]   Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity [J].
Zhang, YM ;
Weiler-Guettler, H ;
Chen, J ;
Wilhelm, O ;
Deng, YH ;
Qiu, F ;
Nakagawa, K ;
Klevesath, M ;
Wilhelm, S ;
Böhrer, H ;
Nakagawa, M ;
Graeff, H ;
Martin, E ;
Stern, DM ;
Rosenberg, RD ;
Ziegler, R ;
Nawroth, PP .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (07) :1301-1309
[46]   MECHANISM OF THE ANTICOAGULANT EFFECT OF WARFARIN AS EVALUATED IN RABBITS BY SELECTIVE DEPRESSION OF INDIVIDUAL PROCOAGULANT VITAMIN-K-DEPENDENT CLOTTING FACTORS [J].
ZIVELIN, A ;
RAO, LVM ;
RAPAPORT, SI .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (05) :2131-2140